Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7221456 | 0.78 | SMN1; SMN2 (0.44) | CA1CA2CA9TAAR1PTGS1 | |
| SCHEMBL7230439 | 0.76 | TAAR1 (0.53) | CYP2C19TAAR1 | |
| SCHEMBL7452648 | 0.76 | TAAR1 (0.53) | CYP2C19TAAR1 | |
| SCHEMBL7452644 | 0.76 | TAAR1 (0.53) | CYP2C19TAAR1 | |
| SCHEMBL27255526 | 0.75 | CYP2C19 (0.46) | CYP2C9CYP2C19HIF1AITGB3ITGAV | |
| SCHEMBL17318445 | 0.75 | CA1 (0.45) | CA1CA2CA9CA12CD274 | |
| SCHEMBL5002695 | 0.72 | HSD17B10 (0.56) | TAAR1PTGS1PTGS2 | |
| SCHEMBL7223358 | 0.72 | HSD17B10 (0.56) | TAAR1PTGS1PTGS2 | |
| SCHEMBL7225865 | 0.72 | PTGS1 (0.47) | CA1CA2CA9CA12TAAR1 | |
| SCHEMBL27256993 | 0.72 | CYP2C19 (0.42) | CYP2C9CYP2C19HIF1AITGB3ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080236412-A1 | Nano-imprinting method using material having surface energy | NATIONAL APPLIED RESEARCH LABORATORIES (TW) | 2008-10-02 | — | — | US | claimed |
| EP-0050457-A1 | Radiopaque cyanoacrylate compositions | BioNexus, Inc. (US) | 1982-04-28 | — | — | EP | claimed |
| US-12461089-B2 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | CHEMOSENSORYX BIOSCIENCES SA (BE) | 2025-11-04 | — | — | US | disclosed |
| WO-2025043152-A1 | METHODS OF DEALKENYLATIVE AMINATION AND AZIDATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-27 | — | — | WO | disclosed |
| US-20240319168-A1 | OLFACTORY RECEPTOR INVOLVED IN THE PERCEPTION OF MUSK FRAGRANCE AND THE USE THEREOF | CHEMOSENSORYX BIOSCIENCES SA (BE) | 2024-09-26 | — | — | US | disclosed |
| US-11867685-B2 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | CHEMCOM S.A. (BE) | 2024-01-09 | — | — | US | disclosed |
| EP-2975015-A1 | USE OF CATALYST OF SUBGROUP VI ELEMENT FOR PREPARING ORGANIC CHEMICAL PRODUCT FROM LIGNIN | Tianjin University (CN) | 2016-01-20 | — | — | EP | disclosed |
| US-20080236412-A1 | Nano-imprinting method using material having surface energy | NATIONAL APPLIED RESEARCH LABORATORIES (TW) | 2008-10-02 | — | — | US | disclosed |
| EP-1546168-A4 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2008-03-12 | — | — | EP | disclosed |
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | PURDUE RESEARCH FOUNDATION | 2006-05-25 | — | — | US | disclosed |
| EP-1546168-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004012667-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | TP53, POLI, POLK | CYP2C9 3600/4885CYP2C19 3666/4885HIF1A 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.